Low caspofungin exposure in patients in the Intensive Care Unit (original) (raw)
MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting
Juan Caeiro
Clinical Infectious Diseases, 2014
View PDFchevron_right
Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration
J. Belda
International journal of antimicrobial agents, 2017
View PDFchevron_right
Caspofungin PK in critically ill patients after the first and fourth doses: suggestions for therapeutic drug monitoring?
Lorenzo Tofani
Journal of Chemotherapy, 2020
View PDFchevron_right
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
F. Belda
Critical care (London, England), 2017
View PDFchevron_right
A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
Flávio Telles
Clinical Infectious Diseases, 2009
View PDFchevron_right
Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure
Arthur Van Zanten
Clinical pharmacokinetics, 2015
View PDFchevron_right
A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients
Anandi Law
Journal of Antimicrobial Chemotherapy, 2010
View PDFchevron_right
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients
Souha Kanj
Intensive Care Medicine, 2019
View PDFchevron_right
Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period
Flávio Telles
Intensive Care Medicine, 2014
View PDFchevron_right
Epidemiology of candidemia in intensive care units
Emilio Bouza
International Journal of Antimicrobial Agents, 2008
View PDFchevron_right
Risk factors for candidaemia in critically ill patients: a prospective surveillance study
Cristóbal León
Mycoses, 2007
View PDFchevron_right
New options for treatment of candidaemia in critically ill patients
Grzegorz Kofla
Clinical Microbiology and Infection, 2008
View PDFchevron_right
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data
Philippe Montravers
Intensive Care Medicine, 2015
View PDFchevron_right
Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013
Michele Mussap
View PDFchevron_right
Candidemia in intensive care unit patients: Risk factors for mortality
Andreas Voss
Infection, 1997
View PDFchevron_right
Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital
M Basso
Medical Mycology, 2008
View PDFchevron_right
Presepsin and (1,3)-β-D-Glucan as a Tool for Predicting Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients
Robert Bocek
Research Square (Research Square), 2021
View PDFchevron_right
Invasive Candida Infections and the Harm From Antibacterial Drugs in Critically Ill Patients
Morten Bestle
Critical Care Medicine, 2015
View PDFchevron_right
Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Crit Care Med. 2011 Apr;39(4):665-70
Maja Surbatovic
Critical Care Medicine
View PDFchevron_right
Invasive candidiasis in intensive care unit; consensus statement from an Iranian panel of experts, July 2013
Mahboubeh Hajiabdolbaghi
JRSM Open, 2014
View PDFchevron_right
Caspofungin for invasive candidiasis at a tertiary care medical center
Aimee Zaas
The American journal of medicine, 2006
View PDFchevron_right
Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study.
Kriton S Filos
View PDFchevron_right
Determinants of mortality in non-neutropenic ICU patients with candidaemia
quoc nguyen, Monica Slavin
Critical Care, 2009
View PDFchevron_right
Factors influencing caspofungin plasma concentrations in patients of a surgical intensive care unit
Trung Nguyen
Journal of Antimicrobial Chemotherapy, 2007
View PDFchevron_right
A bedside scoring system (???Candida score???) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*
Francisco Alvarez-Lerma
Critical Care Medicine, 2006
View PDFchevron_right